Familial Mediterranean fever and growth: effect of disease severity and colchicine treatment

J Pediatr Endocrinol Metab. 2006 Feb;19(2):155-60. doi: 10.1515/jpem.2006.19.2.155.

Abstract

Objective: To evaluate the effect of disease severity and colchicine treatment on height and weight parameters in children with familial Mediterranean fever (FMF).

Methods: Thirty prepubertal children (19 M, 11 F) were studied retrospectively. Z-score values of height, growth velocity, weight and body mass index were obtained over 1.84 +/- 1.14 years before and 2.58 +/- 1.55 years during colchicine therapy. Disease severity was evaluated by a specific score for FMF.

Results: By comparison to growth before treatment, during colchicine therapy height SDS increased from -1.00 +/- 1.17 to -0.54 +/- 0.96 (p < 0.001) and weight SDS increased from -0.74 +/- 1.09 to -0.47 +/- 1.06 (p = 0.008). An effect of disease severity on growth pattern could not be detected. Height SDS during therapy was negatively correlated with age at colchicine initiation.

Conclusions: Colchicine therapy has a positive effect on both height and weight parameters in children with FMF. Early initiation of treatment is beneficial for height gain.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Body Height / drug effects*
  • Body Mass Index
  • Body Weight / drug effects*
  • Child
  • Child Development / drug effects
  • Child, Preschool
  • Colchicine / therapeutic use*
  • Familial Mediterranean Fever / drug therapy*
  • Familial Mediterranean Fever / physiopathology
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Severity of Illness Index
  • Statistics, Nonparametric

Substances

  • Anti-Inflammatory Agents
  • Colchicine